Endell Veterinary Group Equine Hospital in Wiltshire has stationed an equine veterinary surgeon on the Isle of Wight permanently to ensure that the island's numerous horses can receive rapid treatment when they need it.
Florus Oskam MRCVS is providing a routine and emergency mobile ambulatory service around the island 24 hours a day. Florus also has the back up of mainland ambulatory vets who also spend time on the Island. Appointments with specific vets to visit the island can also be arranged.
Florus said: "We have been providing a veterinary service on the Isle of Wight for the past 30 years and have a very loyal client base. For years they have been asking us for a permanent service on the island and we are delighted to be able to provide it at last."
Anita Niccolls, dressage rider and trainer on the Isle of Wight, added: "It's very reassuring to know that a vet of Florus's calibre is now resident on the Island and that we are able to have continuity of vet care should a horse need further treatment at the practice's equine hospital in Salisbury."
The RCVS Disciplinary Committee has accepted an application for restoration to the RCVS Register by James Main, who was struck off in 2011, following his administration of a prohibited substance to a racehorse and his subsequent attempts to conceal his actions.
At a Disciplinary Committee hearing held on 22 February 2011, Mr Main, a partner in the O'Gorman, Slater, Main & Partners veterinary practice in Newbury was found guilty of serious professional misconduct and his name was removed from the Register. The then-Committee established that, contrary to the British Horseracing Authority's (BHA) rules of racing, Mr Main had injected tranexamic acid into the racehorse 'Moonlit Path' on 19 February 2009, knowing that the horse was to race later that day. He was also found guilty of dishonestly concealing this injection in his practice records as a "pre-race check".
At yesterday's hearing, the Committee noted that the decision to remove Mr Main from the Register had sent a clear message to the profession of the importance of strict compliance with the BHA's Rules of Racing; it was the inevitable consequence of his breaches of those rules and his dishonesty in concealing the administration of the injection. In oral evidence, Mr Main said he accepted the findings and decision of the previous Committee, and he apologised.
The Committee also noted a number of changes since implemented at Mr Main's practice, including a pharmacy review to improve traceability of drugs; withdrawal of the use of tranexamic acid in the management of Exercise Induced Pulmonary Haemorrhage; and a cautious approach to drug withdrawal times. Mr Main's practice had also reviewed its processes to ensure its veterinary surgeons complied with all relevant rules, regulations and guidance, and that any requests by clients to breach these rules would be refused.
The Committee accepted evidence that Mr Main had worked in a management capacity in his practice since 26 March 2011, performing no clinical role, and had undertaken appropriate continuing professional development since being removed from the Register. It also noted the large volume of testimonials and public support presented at the hearing from both veterinary surgeons and clients in the horse world.
Furthermore, it noted that removal had been financially and emotionally detrimental to Mr Main, his family and practice and, if his name were not restored to the Register, there would be a continuing detrimental effect on his family finances and the practice.
Committee Chairman Professor Peter Lees said: "The Committee accepts that Mr Main has found the removal of his name from the Register a humbling and salutary experience and accepts his apologies. It is satisfied that he is very unlikely to breach the rules of racing in the future and does not consider that there is a risk to the future welfare of animals by restoring his name to the Register.
"The Committee does not consider that any further period of erasure would be of benefit either to the public or the veterinary profession."
The Committee directed that Mr Main's name be restored to the Register.
The RCVS Disciplinary Committee has dismissed an application for restoration to the RCVS Register from Dr Janos Nemeth, who was struck off in 2009 for fraudulent registration.
This was Dr Nemeth's second unsuccessful restoration application, and the Committee said it would hear no further application unless the Committee Chairman, advised by the Legal Assessor, considered it to have a reasonable prospect of success.
At the original hearing on the 23rd February 2009, Dr Nemeth, who had practised in the Wokingham area of Berkshire, was found to have dishonestly entered his name in the RCVS Register. Although he held a veterinary science degree from the Szent István University in Budapest, he had included a forged document in his registration application. He lodged an appeal with the Privy Council the following month, but did not pursue it; the appeal was dismissed in September 2009 and his name was removed from the Register. Dr Nemeth was ordered to pay costs of £8,904.59, which remain outstanding.
In September 2010, he applied to the RCVS Disciplinary Committee for restoration of his name to the RCVS Register, denying that he had produced a fraudulent document. In refusing the application, the then-Committee told Dr Nemeth that it had no appellate jurisdiction and that the onus was on him to demonstrate that he was a fit and proper person, before his name could be restored. It advised him generally about a future application for restoration.
At this week's restoration hearing, Dr Nemeth told the Committee that he did accept the original findings of the Committee but, at the same time, told them again that he was not party to the forgery. He also said that he held a licence to practise from the Hungarian Veterinary Chamber, and had been employed since October 2011 as a veterinary surgeon in a small animal hospital in Budapest, where he carried out a wide range of work including surgery. He also said he had attended two CPD courses.
The Committee accepted this. However, it continued to be concerned about the absence of evidence. Dr Nemeth had not produced evidence of CPD undertaken or provided letters of support from employers or colleagues, to give comfort to the assertion that he should be permitted to practise in the UK. The Committee rejected Dr Nemeth's argument that his licence to practise in Hungary meant he did not need to do this.
Committee Chairman Professor Peter Lees said: "The Committee is disappointed by Dr Nemeth's continuing lack of insight and is satisfied that he has paid insufficient attention to the guidance given at the previous restoration hearing. The burden remains on him to satisfy this Committee that he is a fit and proper person, before his name can be restored to the Register."
The application was dismissed.
BVA members who join the Webinar Vet before the end of this month will receive a USB headset and microphone worth £40
Webinar Vet founder Anthony Chadwick MRCVS said: "The idea is to help new members get equipped and ready to listen and ask questions during the regular Thursday evening member webinars."
"BVA members already benefit from half price gold membership to the Webinar Vet and many have already taken advantage and are enjoying the many benefits of online CPD."
Gold membership includes invitations to weekly members' live CPD events, full access to the library of over 150 hours of categorised pre-recorded webinars, and a monthly CD of one of the presentations to listen to in the car.
All BVA members who sign up before March 31st will also qualify for the free headset. For more information visit www.bva.co.uk/webinar.
Virbac Animal Health has launched an enhanced version of its flea and tick spot-on Effipro (fipronil) to help pet owners master the art of 'spotonologyTM - a Maureen-Lipmanesque term the company has coined to describe the optimum application of a spot on treatment.
Effipro is now presented in a clear pipette featuring 'Drop-lock' technology to provide precise finger tip control of the flow of liquid with no risk of drip or leakage. The pipette has also been redesigned to ensure it is simple to open and that users can easily check that all the treatment has been dispensed.
Virbac says Effipro is priced to offer an effective but affordable solution to parasite control. It is presented in client packs of four pipettes and in practice packs of 24 to offer flexible dispensing opportunities. It is also available in a spray form.
Victoria Hudson, Product Manager at Virbac, said: "Parasite control is a key revenue generator for many practices. It also presents a great opportunity to create loyal, bonded clients as fleas and ticks cause great concern to pet owners.
"Effipro is already a popular product but we know that some owners find using spot-ons difficult and worry about the risk of the liquid getting on to their fingers or on furniture, particularly if their pets move around while the treatment is being applied.
"With this in mind, we've taken a fresh look at the technology of spot-ons in order to ensure that we're providing a solution which is as simple and hassle-free as possible. As a first step, we've redesigned our pipette. Our unique Drop-lock technology means that owners can start or stop the flow of liquid with their finger tips, giving them full control over where and when the product is applied. The new see-through design and enhanced opening mechanism also make the new version of Effipro more convenient to use.
"We've had great feedback from practices which have trialled the product and believe it represents a significant step forward for users of spot-ons. We are, of course, providing a range of support materials and product promotions to support its launch and look forward to working with our customers to ensure that their clients become expert and enthusiastic 'Spot.on.ologists' during 2012.
For further information about Effipro contact your Territory Manager or call Virbac on 01359 243243.
Henry Schein Inc., parent company of Henry Schein Animal Health has been named as one of Ethisphere's 2012 World's Most Ethical Companies.
The Ethisphere Institute is an international think-tank dedicated to the creation, advancement and sharing of best practices in business ethics, corporate social responsibility, anti-corruption and sustainability. This is the sixth year that Ethisphere Institute has published the World's Most Ethical Companies list.
Out of more than 5,000 nominations for the World's Most Ethical Companies award this year, Henry Schein was named to the list of 145 companies for raising the bar for ethical standards within the health care industry through exemplary ethical leadership, worldwide business standards and commitment to corporate social responsibility.
Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, Inc. said: A deep commitment to the highest ethical standards and business practices has been a hallmark of Henry Schein since our founding in 1932, and continues to be at the very core of our business model as we have grown to become a Fortune 500 company with operations around the globe and nearly 15,000 Team Schein Members."
Virbac Animal Health has launched a special scheme to encourage farmers to have milk samples analysed in line with the industry-wide campaign to promote the responsible use of antimicrobials.
Under the terms of the scheme, veterinary surgeons purchasing Virbac's Cephaguard DC therapy will receive vouchers to distribute to their farmer clients. These vouchers can be redeemed for milk bacteriology to determine the pathogens causing mastitis and so ensure treatment is more targeted and effective.
Brigitte Goasduf MRCVS, Ruminants Marketing Manager at Virbac, said: "Mastitis is a major concern for dairy farmers with reported numbers of cases ranging from 26-50 for every 100 cows.
"Experts agree that individual SCC monitoring and the accurate diagnosis of pathogens causing infection are key to treating mastitis effectively. Unfortunately many farmers are often deterred by the cost.
"Our scheme gives our veterinary customers the opportunity to foster good practice by encouraging farmer clients to submit milk samples for investigation at no cost to them. This will then enable them to treat the bacteria causing the infection in line with industry guidelines for the use of antimicrobials.
"Over time, we believe farmers will come to realise that adopting this more targeted approach is not only more cost-effective but will also preserve their ability to treat their herd, both now and in the future."
For further information on the scheme, contact your Virbac territory manager or call Virbac on 01359 243243.
The RCVS and BVA have expressed their concern about a BBC Newsline report last week of suspected badger baiting in Northern Ireland, which also alleged that veterinary surgeons might be complicit in this illegal activity by not reporting cases of suspiciously injured animals to the relevant authorities.
Bert Allison MRCVS, President of the North of Ireland Veterinary Association, said: "Our Association, and veterinary surgeons across Northern Ireland and Great Britain, are sickened and appalled by these activities. We are grateful to the BBC for highlighting the problem and bringing it to the attention of the public.
"Veterinary surgeons work under a professional code of conduct to uphold animal health and welfare and care deeply about the animals under their care. The claim by USPCA that veterinary surgeons are deliberately failing to report incidents is therefore shocking.
"However, if there is evidence that this has happened the USPCA must provide all relevant information to the Royal College of Veterinary Surgeons which is the statutory regulator of the veterinary profession.
"Under our professional code all veterinary surgeons must provide treatment to alleviate the suffering of an animal presented to them however the gangs abusing these animals may be obtaining veterinary care by deception. We are contacting our members urgently to offer support and remind them how to report suspected incidents safely and within the law."
The RCVS says it has yet to be presented with any evidence to support the claims, but will investigate any genuine complaint supported by first-hand evidence.
The College is also reminding veterinary surgeons about its guidance concerning breaching client confidentiality where a veterinary surgeon believes that animal welfare or the public interest may be compromised.
If there is suspicion of animal abuse, as a result of examining an animal, a veterinary surgeon should consider whether the circumstances are sufficiently serious to justify breaching the usual obligations of client confidentiality.
In cases where discussing these concerns with the client would not be appropriate, or where the client's reaction increases rather than allays these concerns, the veterinary surgeon should contact the relevant authorities, for example the RSPCA, SSPCA or USPCA, to report alleged cruelty to an animal.
Such action should only be taken when the veterinary surgeon considers on reasonable grounds that the public interest in protecting an animal overrides the professional obligation to maintain client confidentiality.
A veterinary surgeon may contact the RCVS for advice before any confidential information is divulged (020 7202 0789 / profcon@rcvs.org.uk).
Research carried out by the Kennel Club to coincide with Mother's Day has revealed that 35% of dog buyers do not see their new puppy with its mother.
The research also found that one in ten buyers take their puppy home before it is eight weeks old, and that 55% do not see the puppy in its breeding environment.
Bill Lambert, Manager of the Kennel Club Assured Breeder Scheme, said: "March is the most popular month for searching for a puppy, but we are extremely concerned that so many are not seeing their puppy with its mother. Seeing mum not only helps people to find out how their puppy will be likely to turn out in terms of temperament and characteristics, but it also gives them the reassurance that it has been bred in a loving environment where it has been cared for and socialised properly."
Marc Abraham, TV vet and Kennel Club Veterinary Advisor, said: "Puppies depend on their mums in the early weeks of life, not just for milk but she's also critical for developing their socialisation skills which help set them up for life. If a breeder refuses to show the puppy with its mother without very good reason, then buyers should go elsewhere."
The Kennel Club is urging people to see puppies with their mother as part of its Stop Puppy Farming campaign and is joining with Marc Abraham to support the 'Where's Mum?' campaign. Kennel Club research has shown that as many as one in four could unwittingly be buying their puppy from a puppy farm.
The Kennel Club will be running a National Puppy Awareness Week (PAW) from the 8th - 14th September. To find out more visit www.thekennelclub.org.uk/stoppuppyfarming.
Animalcare has launched Emdocam (meloxicam 20mg/ml), a non-steroidal anti-inflammatory drug (NSAID) of the oxicam class for use in cattle, pigs and horses.
According to the company, Emdocam disrupts the inflammatory cascade by inhibiting prostaglandin synthesis. It is a potent and preferential inhibitor of COX-2, permitting sufficient COX-1 sparing activity. It has analgesic and anti-inflammatory effects. When administered in a single dose to cattle, it has long acting anti-endotoxic, anti-pyretic and anti-inflammatory effects for up to three days.1,2
In cattle, it is indicated for bovine respiratory disease (BRD), clinical mastitis and calf scour. Animalcare says early use of meloxicam for BRD reduces pyrexia and pain, especially in young calves and improves feed intake. Meloxicam plus an antibiotic significantly reduced the extent of lung lesions, leading to improved clinical efficacy and daily liveweight gain in comparison with animals treated with antibiotics alone, for example oxytetracycline,3 florfenicol4and tilmicosin. 5
In the case of clinical mastitis, Animalcare says that used adjunctively with an antibiotic, Emdocam helps relieve local and systemic inflammation, returns the udder to a normal condition and reduces the polymorphonuclear leucocytes (PMN) response. In a large scale, double-blinded study in New Zealand, the addition of meloxicam to antibiotic therapy resulted in lower Somatic Cell Counts and a reduced risk of culling in dairy cows with mild clinical mastitis.6
Calf scour treated with meloxicam, as a supportive therapy, can improve calf well-being and reduce morbidity. In a double-blinded, controlled study, the use of meloxicam improved daily water and feed intake, added greater average bodyweight (bw) gain and helped calves to wean earlier. 7
In horses, administered IV at 3.0ml/100kg bw, Emdocam can be used for musculo-skeletal disorders, as well as colic, resulting in reduced pain and inflammation. In a study of 18 horses comparing flunixin with meloxicam and designed to determine the effect on recovery of ischemic-injured jejunum, meloxicam was found to be a useful alternative for the post-operative treatment of colic. 8
Emdocam is also indicated in pigs for non-infectious locomotive disorders and as an adjunctive therapy with an antibiotic in puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome).
Tony Liepman from Animalcare said: "Emdocam is competitively priced whether used on its own or adjunctively with a long-acting intramuscular (IM) antibiotic, such as Florgane suspension for the treatment of BRD in calves. This, coupled with its long lasting, low volume (2.5ml/100kg bw in cattle), single dose administration, by intravenous (IV) or subcutaneous (SC) injection, makes Emdocam a highly efficacious and practical NSAID."
Emdocam is a POM-V medicine and available as 50 and 100ml multi-dose vials. Withdrawal period in cattle for meat and offal is 15 days and in pigs for meat and offal is 5 days. In horses for meat and offal it is 5 days. In Florgane [POM-V], the withdrawal period for meat and offal is 37 days in cattle and not to be used in cattle producing milk for human consumption
References
Cattle
Eurovet Animal Health has launched Thyforon Flavoured (levothyroxine sodium, POM-V), which replaces the company's canine hypothyroid treatment Forthyron.
Eurovet says that Thyforon Flavoured has the same clinical efficacy of Forthyron and veterinary surgeons won't need to make any dose adjustments when transitioning to the new product.
However, Thyforon Flavoured, with its palatable formulation, now offers the benefit of being voluntarily accepted by over 70 per cent of dogs in taste trials1. In addition there is a new 800 mcg formulation which gives more prescribing options, particularly for the treatment of large and giant breeds.Thyforon Flavoured comes as easy-break tablets to make dose adjustment straightforward, in an easy-to-dispense blister pack.
Thyforon Flavoured is available now - the person responsible for placing the practice drug order should just ask for Thyforon Flavoured when placing the next drug order and where appropriate, the practice management system should be updated to reflect the new name.
Reference1. Eurovet Animal Health Internal Study report, acceptance study, November 2011
Colonel Neil Smith has been elected Vice-President of the Royal College of Veterinary Surgeons. He takes up office at RCVS Day on 6 July 2012.
Neil graduated from the Royal Veterinary College in 1989, and was commissioned into the Royal Army Veterinary Corps (RAVC) with the intention of staying for four years. Twenty-two years later, he is now the Director Army Veterinary and Remount Services, effectively the Chief Veterinary Officer for the Army and head of the RAVC, which currently has over 35 Veterinary Officers.
He has held a mixture of clinical, staff and command positions, and has worked in the UK, US and Germany. He has Masters' Degrees in Food Science, Defence Administration and Defence Studies. He has also worked part-time in small animal practice (including the Blue Cross, of which he is now a Trustee), and was heavily involved in the Foot and Mouth Disease outbreak in 2001.
First elected to Council in 2004, Neil was re-elected in 2010 after a short break. He has served on Education, Advisory, Preliminary Investigation and Planning and Resources Committees, and on VN Council (currently Vice-Chairman and Chairman of the Awarding Body).
He has also previously been President of the RVC Student Union Society, the RVC Alumnus Association, Southern Counties, and the Association of Government Veterinarians. He is currently a Council member of the Central Veterinary Society, and has previously sat on the BVA's Veterinary Policy Group.
Neil said: "I am honoured to have been elected as the next Vice-President. The College is about to go through some significant organisational changes, not least because of the proposed legislative reform order. However, I aim to ensure that we remain focused on our primary role in safeguarding the health and welfare of animals committed to veterinary care. The functions of the RCVS are quite diverse, and I am keen that we try to enhance both the profession's and the public's understanding of our remit, including our responsibility for educational, ethical and clinical standards."
Jacqui Molyneux has been confirmed as President, and Dr Jerry Davies as Vice-President, effective July 2012.
Burgess Excel has extended its range with what it claims is the UK's most absorbent paper bedding for rabbits, guinea pigs and chinchillas, and a new 'sensitive' variety of nuggets for rabbits and guinea pigs.
Burgess says the bedding is made from environmentally-friendly high quality virgin wood pulp which locks away moisture and liquids quickly and securely. The company also highlights the fact that it is made using advanced, specialised drying and dust extraction techniques to prevent respiratory problems and eye infections which can occur when there is a large amount of dust present in a fibrevore's environment.
The new rabbit and guinea pig nuggets contain 46% Beneficial Fibre with a grain free recipe for delicate digestive systems.
To find out more about the new products, visit www.excelfeedingplan.com/ or contact 0800 413 969.
Virbac Animal Health has launched a broad spectrum wormer for dogs called Endogard (praziquantel, pyrantel and febantel).
Virbac says Endogard offers treatment against most types of intestinal worms found commonly in dogs. It is presented in two tablet sizes for easy dosage.
Victoria Hudson, Product Manager for Endo and Ectoparasiticides, said: "While we're known for developing innovative products which help practices generate additional revenue streams, we can also support them by offering cost-effective and proven products for routine use.
Endogard is a perfect example. The efficacy of its active ingredients is well-established; it's simple for owners to administer and it's also affordable which will bring them back to the practice. It's an excellent addition to Virbac's strong range of parasite control treatments."
For further information, contact your Territory Manager or call Virbac on 01359 243243.
Following the news on Friday that a Bulldog and Pekingese had failed their vet checks at Crufts, a further four animals have failed: Chervood Snowsun, a Clumber Spaniel; Secret Charm Avec Dibest, a Mastiff; Ithani, a Neapolitan Mastiff and Ch Buzz Lightyear At Dereheath, a Basset Hound. All were disqualified from winning Best of Breed, or representing their breed for the remainder of the competition.
The veterinary checks have been introduced by the Kennel Club to ensure that Best of Breed awards are not given to any dogs that show visible signs of problems due to conditions that affect their health or welfare.
Dog World magazine appears to have got hold of a copy of the Clumber Spaniel's Veterinary Health Check Record, and interviewed the owner:
The vet checks have, predictably, polarised opinion. The owners of the Bulldog Mellowmood One In A Million have already setup a facebook page: 'A group dedicated to honoring the win of Ch Mellowmoods One in a Million AKA Jenny who was wrongfully stripped of her Best of Breed win at Crufts based on a political move by the Kennel Club.'
Elsewhere, there has been a considerable amount of support for the vet checks:
The Kennel Club has announced that the Crufts Best of Breed (BOB) winners in two of the high profile breeds - the bulldog and the Pekingese - failed their veterinary checks, so the breeds were not represented in the utility and toy group judging.
The British Veterinary Association says it welcomed the Kennel Club's initiative to put the veterinary checks in place for the BOB winner in the 15 high profile breeds at all championship dog shows starting at Crufts this year.
The 15 breeds have been identified as having particular health problems often due to poor conformation as a result of having been bred with exaggerated characteristics. The veterinary checks ensure the BOB winners are not suffering as a result of their conformation, such as eye problems, skin disease, lameness or breathing difficulties, which should have been identified by the judge.
Carl Padgett, President of the BVA, said: "Breeding dogs with exaggerated features must be tackled robustly. The veterinary checks are sending out a strong message that dogs with health problems will not win in the show ring, and only visibly healthy dogs will be rewarded.
"Dog showing can be a force for good for dog breeding and education but the veterinary checks on the first two groups at Crufts have highlighted the health problems that all too often affect man's best friend.
"We hope this strong action by the Kennel Club will be a wake-up call to those breeders and judges that still need to embrace the message that health should always be at the top of the agenda."
Hill's Pet Nutrition is to launch Prescription Diet y/d Feline for the nutritional management of feline hyperthyroidism in May.
According to the company, hyperthyroidism is the most commonly diagnosed endocrinopathy in cats globally, and is thought to affect around 10% of cats over the age of nine in the UK.1.
Prescription Diet y/d Feline is clinically proven to manage thyroid health in three weeks3 and gives vets a new management modality to address the needs of hyperthyroid cats. Hill's says that the new product is essentially a low iodine food; production of thyroid hormones T3 and T4 require iodine molecules, so limiting the amount of dietary iodine reduces the amount of thyroid hormones produced and released by the thyroid gland.
Hill's highlights three key studies in peer reviewed veterinary journals which the company says demonstrates the efficacy of y/d.2-4 The research identified that limiting the amount of iodine consumed resulted in a lowering of T4 (serum total thyroxine) to normal levels, with significant reductions in just 3 weeks.2
Hill's says that the availabillity of nutrition as a treatment option marks a major step forward from invasive surgery, treatment with radioactive iodine - which is available in only a few centres in the UK - or pilling, which can prove to be particularly difficult for some pet owners. The company adds that a gradual transition to y/d is also an option where medical treatment is proving problematic.
Cats with hyperthyroidism have a multisystemic disease and concurrent problems can develop, such as hypertension, cardiovascular abnormalities and recurrent urinary infections. Additionally, many older cats with hyperthyroidism have concurrent renal dysfunction, which is often 'unmasked' when the hypertension is bought under control. Therefore, y/d also has controlled levels of phosphorus and low sodium for renal and circulatory health, reduced magnesium and moderate urine pH target for urinary health and taurine and carnitine for heart health.
Hill's Prescription Diet y/d Feline will be available from 1st May.
For more information, visit www.catthyroidhealth.com
1. Symes H, Winter 2008/2009. Feline hyperthyroidism. The Endocrinologist. Issue 90, pp 10-12. Symes H, Winter 2008/2009. Feline hyperthyroidism. The Endocrinologist. Issue 90, pp 10-12.2. Controlled level of dietary iodine normalizes serum total thyroxine in cats with naturally occurring hyperthyroidism Yu S, Wedekind KJ, Burris PA, et al. J Vet Intern Med 2011;25:683-684 (abstract).3. Titration of dietary iodine for reducing serum thyroxine concentrations in newly diagnosed hyperthyroid cats Melendez LD, Yamka RM, Forrester SD, et al. J Vet Intern Med 2011;25:683 (abstract).4. Titration of dietary iodine for maintaining normal serum thyroxine concentrations in hyperthyroid cats Melendez LD, Yamka RM, Burris PA. J Vet Intern Med 2011;25:683 (abstract).
The candidates for this year's RCVS Council election have been announced, many of whom will be coming to the VetSurgeon.org forums to lay out their stalls and explain why you should vote for them.
A record number of veterinary surgeons - 14 - are contesting six seats in the RCVS Council election. Veterinary surgeons may each vote for up to six candidates to fill these seats, which fall vacant as elected Council member's terms of office expire at the RCVS Annual General Meeting (6 July). In 2012, five existing Council members are seeking re-election, and nine new candidates are standing.
Of the 42 RCVS Council members, four are appointed by the Privy Council, 14 by the veterinary schools and 24 by direct election; each member serves a four year term. This year's candidates are:
Voting opens from Friday 9 March and all veterinary surgeons eligible to vote should receive their ballot papers shortly. Votes must be received by 5pm on 27 April 2012 and, as in previous years, can be cast online, by post, or by text message
Novartis Animal Health has announced that it is offering regular updates Schmallenberg virus, including the number and counties of affected farms, on its farm animal health website: www.farmanimalhealth.co.uk.
The new website is a resource for vets, SQPs and farmers and also contains background information on the virus, its symptoms and suggestions for control.
Helen Langham, Brand Manager at Novartis Animal Health, said: "There is still a lot that isn't known about the Schmallenberg virus, so it is essential that those involved in the animal health industry and livestock production are kept informed. Our website provides current information and links to relevant resources to help people stay up to date".
For more information go to www.farmanimalhealth.co.uk/latestdiseaseupdates
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
Over 100 students from Nottingham Vet Society will attempt the 3 Peaks Challenge by climbing Ben Nevis, Scafell Pike and Snowdon in under 24 hours on 10 March.
The funds raised will be split between VBF, the charity that supports veterinary professionals, and Medical Detection Dogs.
Online donations can be made at http://goo.gl/IkodW.
Lydia Brown, VBF President, said: "We are so grateful to the students involved who organized this off their own backs even though they don't have much free time. It augurs well for the future of the profession that they want to support their colleagues. I do hope they all make it back to Nottingham safely and I look forward to seeing the pictures on facebook.com/VetlifeVBF! "
Tom McKay, one of the students who organized the challenge, said: "We have really enjoyed the training and are reasonably optimistic we will make it back for our Easter placements!"
Boehringer Ingelheim is offering a free stainless steel bolus applicators, worth £42.60/€ 59.39 (plus VAT), with the first 1,000 Bovikalc multipacks sold after 1st March in the UK and Eire.
According to the company, milk fever is recognised as the most common mineral deficiency affecting transition cows; one that has a significant impact on the overall health of affected animals, even those showing no outward symptoms. This offer aims to help combat this costly but preventable disease.
The offer is open to farmers, vets and suppliers of Bovikalc and one free applicator will be provided for each Bovikalc multipack - 6 x 4 boluses.
Farmers are required to apply for the free applicators through their veterinary surgeon or Bovikalc supplier.
For further information, including the terms and conditions of the offer, visit www.bovikalc.co.uk. Alternatively, contact your regional cattle specialist or call Boehringer on 01344 746959.
The BSAVA has released a statement in support of the television programme Pedigree Dogs Exposed - three years on, made by Jemima Harrison. The programme was broadcast earlier this week on BBC4 as a follow up to a documentary which was first shown in 2008.
BSAVA President Andrew Ash said: "Jemima Harrison has highlighted an important issue. It is essential that veterinary surgeons, dog breeders and the general public no longer accept that breeding for extremes of conformation or knowingly from animals with inherited disease is an acceptable practice. The programme highlighted two main areas of concern, firstly the small genetic pool that exists in many breeds and secondly continued breeding for extremes of body shape. Both these areas must be addressed urgently. A civilised nation must agree that it is not acceptable to breed dogs that cannot function as dogs."
He went on to say that: "BSAVA supports the health schemes that are now available to owners as steps in the right direction. However it is difficult to believe that health schemes are going to be sufficient in themselves to tackle these problems rapidly and effectively. It is particularly perverse to be promoting health schemes and yet continuing to allow the registration and showing of progeny with Coefficients of Inbreeding as high as 47.5% or where the animal concerned is known to have failed a screening test (significant in that breed)."
Vice President Mark Johnson said: "We are supportive of the changes that the Kennel Club has made so far, and applaud them in allowing the introduction of new genes into certain breeds as demonstrated by the registration of the LUA Dalmatian. I support the introduction of the "Mate Select" scheme (link) but believe that the Kennel Club should adopt the Advisory Council on Welfare in Dog Breeding recommendation and not register puppies with a coefficient of breeding (over 5 generations) greater than 12.5%."
The BSAVA says it supports the BVA in its call for a radical review of all breed standards to ensure that they actively protect the health and welfare of the dog. However it is important to remember that inherited disease is not just a problem of purebred dogs and BSAVA supports the introduction of legislation that seeks to improve the health and welfare of all dogs.
A new study has revealed that owners of obese dogs which successfully lose weight notice significant improvement in their dogs' quality of life too.
The study, published in The Veterinary Journal and available online here, was conducted by scientists from the Royal Canin Weight Management Clinic at Liverpool University in conjunction with the Pain and Welfare Group at the University of Glasgow and the Waltham Centre for Pet Nutrition. It looked at fifty obese dogs that had been referred to Royal Canin's clinic.
The results showed that quality of life improved in the dogs that successfully lost weight, demonstrated by increased vitality scores and decreased scores for emotional disturbance and pain. The improvements in vitality score were greater the more body fat the dogs lost. The research also found that the dogs that failed to complete their weight loss programme had lower vitality and higher emotional disturbance scores than those successfully losing weight.
Dr. Alex German, Royal Canin senior lecturer at the University of Liverpool and lead author of the study, said: "Obesity is a risk for many dogs, affecting not only their health, but also their quality of life. The results indicate that, for obese dogs, weight loss can be important for staying both healthy and happy."
Owners completed a questionnaire to determine the health-related quality of life of their dog prior to weight loss, with a follow-up questionnaire for the owners of the thirty dogs that successfully completed the weight loss programme to reach target weight. The completed questionnaire responses were converted into scores corresponding to a range of factors, including vitality, emotional disturbance and pain.
Boehringer Ingelheim Vetmedica has launched Benefortin (benazepril hydrochloride), an ACE inhibitor licensed for the treatment of congestive heart failure (CHF) in dogs. It is also licensed for the treatment of chronic renal insufficiency (CRI) in cats.
Benefortin uses novel micro-cap technology to mask the taste of the bitter molecule. According to Boehringer, this ensures that Benefortin tastes good1, even if it is bitten, crunched or chewed. The company says taste tests demonstrated 100% palatability in dogs and 92% palatability in cats in home settings1.
Benefortin is available in 5mg and 20mg tablets for dogs and 2.5mg tablets for cats and dogs.
Jemima Scott, Boehringer Ingelheim brand manager said: "The addition of Benefortin to our cardiology portfolio now enables us to provide veterinary practices with two of the cornerstones of canine CHF treatment, and the palatability of Benefortin makes it an excellent choice for vets needing to prescribe an ACE inhibitor."
To support the launch of Benefortin, Boehringer is offering veterinary practices the opportunity to win one of three Bosch microwave ovens in a prize draw by answering three multiple choice questions on the ACE inhibitor.
For further information on Benefortin, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.